16.66 Delayed Data As of Apr 25 | ![]() Today’s Change | 3.82 Today|||52-Week Range 26.05 | -0.77% Year-to-Date |
Previous close | 16.78 |
Today’s open | 16.73 |
Day’s range | 16.11 - 16.95 |
Volume | 361,448 |
Average volume (3 months) | 805,907 |
Market cap | $612.6M |
Earnings growth (last year) | +24.67% |
Earnings growth (this year) | +58.41% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -100.00% |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 5.12 |
Today’s change | Today’s % change | |
---|---|---|
AVEOAveo Pharmaceuticals... | +0.03 | +1.16% |
SVASinovac Biotech Ltd | -0.01 | -0.13% |
CRBPCorbus Pharmaceutica... | -0.05 | -0.79% |
DEPODepomed Inc | -0.16 | -2.34% |
Next reporting date | May 9, 2018 |
EPS forecast (this quarter) | -$0.28 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$33.3M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Rachel K. King |
CFO, Secretary & Principal Accounting Officer Brian M. Hahn |
Corporate headquarters Rockville, Maryland |